Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Megan D. Gertzen"'
Autor:
Arden B. Piepho, Jeovanna Lowe, Laurel R. Cumby, Lisa E. Dorn, Dana M. Lake, Neha Rastogi, Megan D. Gertzen, Sarah L. Sturgill, Guy L. Odom, Mark T. Ziolo, Federica Accornero, Jeffrey S. Chamberlain, Jill A. Rafael-Fortney
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 28, Iss , Pp 344-354 (2023)
Micro-dystrophin gene replacement therapies for Duchenne muscular dystrophy (DMD) are currently in clinical trials, but have not been thoroughly investigated for their efficacy on cardiomyopathy progression to heart failure. We previously validated F
Externí odkaz:
https://doaj.org/article/112376132c914e0588ee19091b2c6a91
Autor:
Zachary M. Howard, Lisa E. Dorn, Jeovanna Lowe, Megan D. Gertzen, Pierce Ciccone, Neha Rastogi, Guy L. Odom, Federica Accornero, Jeffrey S. Chamberlain, Jill A. Rafael-Fortney
Publikováno v:
JCI Insight, Vol 6, Iss 7 (2021)
Gene replacement for Duchenne muscular dystrophy (DMD) with micro-dystrophins has entered clinical trials, but efficacy in preventing heart failure is unknown. Although most patients with DMD die from heart failure, cardiomyopathy is undetectable unt
Externí odkaz:
https://doaj.org/article/edf8afa3bfcf4133a3ecce62112683f8
Autor:
Neha Rastogi, Lisa E. Dorn, Megan D. Gertzen, Jeovanna Lowe, Zachary M. Howard, Guy L. Odom, Jill A. Rafael-Fortney, Jeffrey S. Chamberlain, Federica Accornero, Pierce C. Ciccone
Publikováno v:
JCI Insight, Vol 6, Iss 7 (2021)
JCI Insight
JCI Insight
Gene replacement for Duchenne muscular dystrophy (DMD) with micro-dystrophins has entered clinical trials, but efficacy in preventing heart failure is unknown. Although most patients with DMD die from heart failure, cardiomyopathy is undetectable unt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5b194e6e4ff3065281aa84d4f9b50d2
https://doaj.org/article/edf8afa3bfcf4133a3ecce62112683f8
https://doaj.org/article/edf8afa3bfcf4133a3ecce62112683f8